Ameliorative effect of chrysin on adenine-induced chronic kidney disease in rats

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Ali, Badreldin H ^a   Adham, Sirin A ^a   Al Za'abi, Mohammed ^a   Waly, Mostafa I ^a   Yasin, Javed ^b   Nemmar, Abderrahim ^b   Schupp, Nicole ^c  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ADIPONECTIN; ALBUMIN; CATALASE; CHRYSIN; CREATININE; CYTOKINE; ENDOTHELIN 1; GLUTATHIONE; INDICAN; INTERLEUKIN 1BETA; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SCLEROSTIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UREA; ACETYLGLUCOSAMINIDASE; ANTIOXIDANT; FLAVONOID; LIPOCALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; INFLAMMATION; KIDNEY FUNCTION; KIDNEY HOMOGENATE; KIDNEY STRUCTURE; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; RENAL PROTECTION; UREA BLOOD LEVEL; ANIMAL; BLOOD; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; FIBROSIS; KIDNEY; KIDNEY FUNCTION TEST; METABOLISM; NEUTROPHIL; PATHOLOGY; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC; WISTAR RAT;

RATTUS;

ACETYLGLUCOSAMINIDASE; ADENINE; ANIMALS; ANTIOXIDANTS; CREATININE; DISEASE MODELS, ANIMAL; FIBROSIS; FLAVONOIDS; INFLAMMATION; KIDNEY; KIDNEY FUNCTION TESTS; LIPOCALINS; MALE; NEUTROPHILS; OXIDATIVE STRESS; RATS; RATS, WISTAR; RENAL INSUFFICIENCY, CHRONIC; UREA;

EID: 84929379145     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125285     Document Type: Article

References (43)

1. Hanson L, Haynes LK, Turiano L. Chronic kidney disease in Central America: the big picture. Am J Public Health. 2014; 104: e9. doi: 10.2105/AJPH.2014.302295 PMID: 25320888
2. Sengul S, Erdem Y, Batuman V, Erturk S. Hypertension and chronic kidney disease in Turkey. Kidney Int Suppl. 2011; 3: 308-311.
3. Yamagata K, Yagisawa T, Nakai S, Nakayama M, Imai E, Hattori M, et al. Prevalence and incidence of chronic kidney disease stage G5 in Japan. Clin Exp Nephrol. 2015; 19: 54-64. doi: 10.1007/s10157-014-0978-x PMID: 24821288
4. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011; 80: 1258-1270. doi: 10.1038/ki.2011.368 PMID: 21993585
5. Hall ME, do Carmo JM, da Silva AA, Juncos LA, Wang Z, Hall JE. Obesity, hypertension, and chronic kidney disease. Int J Nephrol Renovasc Dis. 2014; 7: 75-88. doi: 10.2147/IJNRD.S39739 PMID: 24600241
6. Kazancioʇlu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl (2011). 2013; 3: 368-371. PMID: 25019021
7. Jablonski KL, Decker E, Perrenoud L, Kendrick J, Chonchol M, Seals DR, et al. Assessment of vascular function in patients with chronic kidney disease. J Vis Exp. 2014; 16.
8. Yilmaz MI, Siriopol D, Saglam M, Kurt YG, Unal HU, Eyileten T, et al. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease. Kidney Int. 2014; 86: 1213-20. doi: 10.1038/ki.2014.227 PMID: 24988065
9. Ali BH, Al-Husseni I, Beegam S, Al-Shukaili A, Nemmar A, Schierling S, et al. Effect of gum arabic on oxidative stress and inflammation in adenine-induced chronic renal failure in rats. PLoS One. 201; 8: e55242. doi: 10.1371/journal.pone.0055242 PMID: 23383316
10. Ali BH, Al-Salam S, Al Za'abi M, Waly MI, Ramkumar A, Beegam S, et al. New model for adenine-induced chronic renal failure in mice, and the effect of gum acacia treatment thereon: comparison with rats. J Pharmacol Toxicol Methods. 2013; 68: 384-393. doi: 10.1016/j.vascn.2013.05.001 PMID: 23669035
11. Yamaguchi S, Inada C, Tamura M, Sato N, Yamada M, Itaba S, et al. Beraprost sodium improves survival rates in anti-glomerular basement membrane glomerulonephritis and 5/6 nephrectomized chronic kidney disease rats. Eur J Pharmacol. 2013; 714: 325-331. doi: 10.1016/j.ejphar.2013.07.032 PMID: 23911885
12. Ali BH, Al-Salam S, Al Husseni I, Kayed RR, Al-Masroori N, Al-Harthi T, et al. Effects of gum Arabic in rats with adenine-induced chronic renal failure. Exp Biol Med (Maywood). 2010; 235: 373-382. doi: 10.1258/ebm.2009.009214 PMID: 20404056
13. Almquist T, Jacobson SH, Mobarrez F, Näsman P, Hjemdahl P. Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease. Eur J Clin Invest. 2014; 44: 276-284. doi: 10.1111/eci.12230 PMID: 24720535
14. Anand KV, Mohamed Jaabir MS, Thomas PA, Geraldine P. Protective role of chrysin against oxidative stress in d-galactose-induced aging in an experimental rat model. Geriatr Gerontol Int. 2012; 12: 741-750. doi: 10.1111/j.1447-0594.2012.00843.x PMID: 22469068
15. Feng X, Qin H, Shi Q, Zhang Y, Zhou F, Wu H, et al. Chrysin attenuates inflammation by regulating M1/M2 status via activating PPARγ. Biochem Pharmacol. 2014; 89: 503-514. doi: 10.1016/j.bcp.2014.03.016 PMID: 24704474
16. Jiang Y, Gong FL, Zhao GB, Li J. Chrysin suppressed inflammatory responses and the inducible nitric oxide synthase pathway after spinal cord injury in rats. Int J Mol Sci. 2014; 15: 12270-12279. doi: 10.3390/ijms150712270 PMID: 25014398
17. Anandhi R, Thomas PA, Geraldine P. Evaluation of the anti-atherogenic potential of chrysin in Wistar rats. Mol Cell Biochem. 2014; 385: 103-113. doi: 10.1007/s11010-013-1819-z PMID: 24065391
18. Rehman MU, Tahir M, Khan AQ, Khan R, Lateef A, Oday-O-Hamiza, et al. Chrysin suppresses renal carcinogenesis via amelioration of hyperproliferation, oxidative stress and inflammation: plausible role of NF-κB. Toxicol Lett. 2013; 216: 146-158. doi: 10.1016/j.toxlet.2012.11.013 PMID: 23194824
19. Rashid S, Ali N, Nafees S, Ahmad ST, Arjumand W, Hasan SK, et al. Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats. Toxicol Mech Methods. 2013; 23: 337-345. doi: 10.3109/15376516.2012.759306 PMID: 23256457
20. Ali N, Rashid S, Nafees S, Hasan SK, Sultana S. Beneficial effects of Chrysin against methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis. Mol Cell Biochem. 2014; 385: 215-223. doi: 10.1007/s11010-013-1830-4 PMID: 24154663
21. Anand KV, Anandhi R, Pakkiyaraj M, Geraldine P. Protective effect of chrysin on carbon tetrachloride (CCl4)-induced tissue injury in male Wistar rats. Toxicol Ind Health. 2011; 27: 923-933. doi: 10.1177/0748233711399324 PMID: 21511893
22. Ali BH, Al-Salam S, Al Za'abi M, Al Balushi KA, Ramkumar A, Waly MI, et al. Does swimming exercise affect experimental chronic kidney disease in rats treated with gum acacia? PLoS One. 2014; 9: e102528. doi: 10.1371/journal.pone.0102528 PMID: 25048380
23. Ali BH, Alza'abi M, Ramkumar A, Al-Lawati I, Waly MI, Beegam S, et al. The effect of activated charcoal on adenine-induced chronic renal failure in rats. Food Chem Toxicol. 2014; 65: 321-328. doi: 10.1016/j.fct.2013.12.038 PMID: 24412558
24. Al Za'abi M, Ali B H, Al Toubi M. HPLC-fluorescence method for measurement of the uremic toxin indoxyl sulfate in plasma. J Chromatogr Sci. 2013; 51: 40-43. doi: 10.1093/chromsci/bms103 PMID: 22718744
25. Ahmad QZ, Jahan N, Ahmad G, Tajuddin. An appraisal of nephroprotection and the scope of natural products in combating renal disorders. J Nephrol Ther. 2014; 4: 170.
26. Huang Y, Lei Y, Zheng Z, Wang X, Hu M, Liu R, et al. Rosiglitazone alleviates injury in rats with adenine induced chronic kidney disease. Mol Med Rep. 2013; 8: 1831-5. doi: 10.3892/mmr.2013.1715 PMID: 24126724
27. Tu Y, Sun W, Wan YG, Gao K, Liu H, Yu BY, et al. Dahuang Fuzi Decoction ameliorates tubular epithelial apoptosis and renal damage via inhibiting TGF-β1-JNK signaling pathway activation in vivo. J Ethnopharmacol. 2014; 156: 115-24. doi: 10.1016/j.jep.2014.08.035 PMID: 25193680
28. Diwan V, Gobe G, Brown L. Glibenclamide improves kidney and heart structure and function in the adenine-diet model of chronic kidney disease. Pharmacol Res. 2014; 79: 104-10. doi: 10.1016/j.phrs.2013.11.007 PMID: 24291534
29. Ahad A, Ganai AA, Mujeeb M, Siddiqui WA. Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats. Toxicol Appl Pharmacol. 2014; 279: 1-7. doi: 10.1016/j.taap.2014.05.007 PMID: 24848621
30. Holmes D. Biomarkers: Sclerostin levels linked to CKD outcomes. Nat Rev Endocrinol. 2014; 10: 577. doi: 10.1038/nrendo.2014.145 PMID: 25112232
31. Desjardins L, Liabeuf S, Oliveira RB, Louvet L, Kamel S, Lemke HD, et al. On behalf of the European Uremic Toxin (EUTox) Work Group. Uremic toxicity and sclerostin in chronic kidney disease patients. J Nephrol Ther. 2014; 10: 463-70. doi: 10.1016/j.nephro.2014.04.002 PMID: 25070604
32. Martín-Pardillos A, Sosa C, Millán Á, Sorribas V. Effect of water fluoridation on the development of medial vascular calcification in uremic rats. Toxicology. 2014; 318: 40-50. doi: 10.1016/j.tox.2014.01.012 PMID: 24561004
33. García-García PM, Getino-Melián MA, Domínguez-Pimentel V, Navarro-González JF. Inflammation in diabetic kidney disease. World J Diabetes. 2014; 5: 431-443. doi: 10.4239/wjd.v5.i4.431 PMID: 25126391
34. Yao Y, Chen L, Xiao J, Wang C, Jiang W, Zhang R, et al. Chrysin protects against focal cerebral ischemia / reperfusion injury in mice through attenuation of oxidative stress and inflammation. Int J Mol Sci. 2014; 15: 20913-20926. doi: 10.3390/ijms151120913 PMID: 25402649
35. Delanaye P, Krzesinski JM, Warling X, Moonen M, Smelten N, Médart L, et al. Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients. Nephron Clin Pract. 2014; 128: 127-34. doi: 10.1159/000366449 PMID: 25377055
36. Ferreira JC, Ferrari GO, Neves KR, Cavallari RT, Dominguez WV, Dos Reis LM, et al. Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease - role of sclerostin? PLoS One. 2013; 8:e79721. doi: 10.1371/journal.pone.0079721 PMID: 24236156
37. Owada S, Goto S, Bannai K, Hayashi H, Nishijima F, Niwa T. Indoxyl sulfate reduces superoxide scavenging activity in the kidneys of normal and uremic rats. Am J Nephrol. 2008; 28:446-54. PMID: 18160814
38. Taki K, Nakamura S, Miglinas M, Enomoto A, Niwa T. Accumulation of indoxyl sulfate in OAT1/3-positive tubular cells in kidneys of patients with chronic renal failure. J Ren Nutr. 2006; 16:199-203. PMID: 16825019
39. Adem S, Comakli V, Kuzu M, Demirdag R. Investigation of the effects of some phenolic compounds on the activities of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase from human erythrocytes. J Biochem Mol Toxicol. 2014; 28: 510-4. doi: 10.1002/jbt.21592 PMID: 25130191
40. Serón D, Burgos D, Alonso A. Histology and proteinuria after renal transplantation. Transplant Rev (Orlando). 2012; 26: 20-26. doi: 10.1016/j.trre.2011.07.009 PMID: 22137728
41. Walle T, Otake Y, Brubaker JA, Walle UK, Halushka PV. Disposition and metabolism of the flavonoid chrysin in normal volunteers. Br J Clin Pharmacol. 2001; 51: 143-6. PMID: 11259985
42. Feng X, Qin H1, Shi Q, Zhang Y, Zhou F, Wu H, et al. Chrysin attenuates inflammation by regulating M1/M2 status via activating PPARγ. Biochem Pharmacol. 2014; 89: 503-14. doi: 10.1016/j.bcp.2014.03.016 PMID: 24704474
43. Romier B, Van De Walle J, During A, Larondelle Y, Schneider YJ. Modulation of signalling nuclear factor-kappaB activation pathway by polyphenols in human intestinal Caco-2 cells. Br J Nutr. 2008; 100: 542-51. doi: 10.1017/S0007114508966666 PMID: 18377686